Fact CheckerSign in

NCT06848205Recruiting

Percept Transitions in FOG and PD

Basal Ganglia Contributions to Transitions in Freezing of Gait and Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 3 Mar 2026

Brief summary (registry, in English)

The purpose of this research is to examine the possible causes and signs of freezing of gait (FOG) secondary to Parkinson's disease (PD). To achieve this, the study will use the novel (on-label and FDA-approved) local field potential (LFP) measuring capability of the Medtronic Percept™ deep brain stimulation (DBS) system to compare oscillatory activity in people who have Parkinson's disease, with and without freezing of gait (FOG). This will be conducted as three separate experiments, participants may volunteer for one or more experiments: Experiment 1: The first experiment will compare LFPs during gait initiation with and without a cue, in people with (PD+FOG) and without FOG (PD-FOG). Experiment 2: The second experiment will compare LFPs during the successful movement transitions vs. freezing-events during a FOG provocation course in people with FOG. Experiment 3: The third experiment will compare LFPs during rapid alternating movements of the wrist and/or foot, in people with and without FOG

Status (registry)
Recruiting
Study type
Interventional
Enrollment
36 (estimated)
First submitted
19 Feb 2025
Start date
26 Feb 2026
Primary completion date
1 Dec 2028
Lead sponsor
University of Minnesota
NCT number
NCT06848205

What you commit to

  • Study type: Interventional
  • Planned participants: 36
  • From 26 Feb 2026 to the primary completion date, 1 Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Meet criteria for dementia with Lewy bodies, Multiple Systems Atrophy, Alzheimer's disease, or other neurodegenerative disorder.
  • History of seizures or other significant neurological disorders that may affect participation or performance in the study.
  • History of musculoskeletal disorders that significantly affect walking or movement of limb(s) that would affect the participation in the experimental task (Participants will be excluded from that task, but may participate in other tasks, for example, may be excluded from Experiment 1 if the disorder affects walking, but may still participate in Experiment 3).
  • History of muscular conditions of the neck and back, including whiplash that would affect walking experiments.
  • History of visual and/or vestibular conditions that may affect participation or performance in the study.

Other

  • Reduced capacity to consent. This will be assessed using a 2-stage process. Initially, participants will be tested using the University of California, San Diego, Brief Assessment of Capacity to Consent (UBACC). If concerns are raised from the UBACC test, the individual will be further tested using the MacArthur Competency Assessment Tool.
  • Pregnant people.
  • Post-operative complications or adverse effects (e.g. ON stimulation dystonia) that affect patient safety or confound the experiment.

Who the study is looking for

  • Diagnosis of idiopathic PD.
  • Age 21-75 (see Inclusion of Individuals across the Lifespan for justification of age range).
  • Able to ambulate independently without the use of an assistive device (e.g. cane) for 50 meters.
  • Implanted Medtronic Percept TM Device.
  • At least 3 months since the initial activation of the neurostimulator.
  • Undervalued, under-represented, or disenfranchised social group may be included.
  • Active members of the military (service members), DoD personnel (including civilian employees) may be included.
  • Individual or group that is disadvantaged in the distribution of social goods and services such as income, housing, or healthcare may be included.

Age in the registry: 21 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Minnesota, Movement Disorders Lab
Coordinator of this site? Confirm its status
MinneapolisUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.